Actinium Pharmaceuticals Inc. appointed Anil Kapur chief commercial officer, effective Feb. 8.
Most recently, Kapur worked at Bristol-Myers Squibb Co. as vice president, head of early assets, biomarkers and external innovation, worldwide oncology commercialization.
